Neoadjuvant chemotherapy versus upfront debulking surgery in advanced tubo-ovarian cancer

被引：10
|
作者：
Fagotti, Anna [1 ,2 ]
Scambia, Giovanni [1 ,2 ]
机构：
[1] Fdn Policlin Univ Agostino Gemelli, IRCCS, I-00168 Rome, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
来源：
LANCET ONCOLOGY | 2018年 / 19卷 / 12期
关键词：
OVARIAN-CANCER;
D O I：
10.1016/S1470-2045(18)30625-9
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1558 / 1560
页数：3
相关论文
共 50 条
  • [31] Clinical significance of primary debulking surgery and neoadjuvant chemotherapy-interval debulking surgery in advanced ovarian cancer
    Nishio, Shin
    Ushijima, Kimio
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2020, 50 (04) : 379 - 386
  • [32] PRIMARY DEBULKING SURGERY VERSUS PRIMARY NEOADJUVANT CHEMOTHERAPY WITH OR WITHOUT INTERVAL DEBULKING SURGERY FOR ADVANCED STAGE OVARIAN CANCER: A SINGLE INSTITUTE STUDY
    Chen, Y. Y.
    Ou, Y. C.
    Lin, H.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A451 - A452
  • [33] NEOADJUVANT CHEMOTHERAPY VERSUS PRIMARY DEBULKING SURGERY IN ADVANCED HIGH GRADE OVARIAN CANCER PATIENTS : A COHORT STUDY
    Girard, N.
    Asmar, J.
    Rance, B.
    Bats, A. S.
    Rossi, L.
    Gosset, M.
    Delomenie, M.
    Bonsang-Kitzis, H.
    Lecuru, F.
    Ngo, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 690 - 690
  • [34] NEOADJUVANT CHEMOTHERAPY VERSUS PRIMARY DEBULKING SURGERY IN ADVANCED HIGH GRADE OVARIAN CANCER PATIENTS : A COHORT STUDY
    Girard, N.
    Asmar, J.
    Rance, B.
    Bats, A. S.
    Delomenie, M.
    Rossi, L.
    Gosset, M.
    Lecuru, F.
    Ngo, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 : 1506 - 1506
  • [35] Neoadjuvant chemotherapy versus debulking surgery in advanced tubo-ovarian cancers: pooled analysis of individual patient data from the EORTC 55971 and CHORUS trials (vol 19, pg 1680, 2018)
    Vergote, I
    Coens, C.
    Nankivell, M.
    LANCET ONCOLOGY, 2019, 20 (01): : E10 - E10
  • [36] Primary Debulking Surgery Versus Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Propensity-matched Analysis
    Siesto, Gabriele
    Cavina, Raffaele
    Romano, Fabrizio
    Vitobello, Domenico
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (03): : 280 - 285
  • [37] Primary debulking surgery vs. neoadjuvant chemotherapy followed by interval debulking surgery for patients with advanced ovarian cancer
    Ce Bian
    Kui Yao
    Li Li
    Tao Yi
    Xia Zhao
    Archives of Gynecology and Obstetrics, 2016, 293 : 163 - 168
  • [38] Neoadjuvant chemotherapy and interval debulking surgery for advanced ovarian cancer, an alternative with multiple advantages
    Medina-Franco, Heriberto
    Mejia-Fernandez, Loreli
    CHINESE CLINICAL ONCOLOGY, 2018, 7 (06)
  • [39] Minimally invasive interval debulking surgery for advanced ovarian cancer after neoadjuvant chemotherapy
    Jorgensen, Kirsten
    Melamed, Alexander
    Wu, Chi-Fang
    Nitecki, Roni
    Pareja, Rene
    Fagotti, Anna
    Schorge, John O.
    Ramirez, Pedro T.
    -Hain, Jose Alejandro Rauh
    GYNECOLOGIC ONCOLOGY, 2023, 172 : 130 - 137
  • [40] IS LAPAROSCOPIC INTERVAL DEBULKING SURGERY ACHIEVABLE FOR ADVANCED OVARIAN CANCER AFTER NEOADJUVANT CHEMOTHERAPY?
    Pellerin, M.
    Lecointre, L.
    Billard-Martel, C.
    Boisrame, T.
    Faller, E.
    Fabacher, T.
    Akladios, C.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A271 - A271
12345